He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug ...

President Donald Trump set a deadline of Sept. 19 for pharmaceutical companies to commit to complying with his demands of ...

President Donald Trump escalated his campaign to pressure pharmaceutical companies to lower drug prices, sending letters to 17 of the world’s largest drugmakers demanding they charge the U.S. what oth ...

(Alliance News) - US pharmaceutical giant Pfizer Inc and German firm BioNTech SE lost Friday a court appeal in the latest step of a multi-million pound battle against US rival Moderna Inc over the ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal has upheld the validity of Moderna's EP'949 patent.

Shares of Pfizer Inc. PFE slid 2.18% to $23.29 Thursday, on what proved to be an all-around dismal trading session for the ...

Pfizer faces weak growth, sector headwinds, and pipeline uncertainty despite cost cuts and a 7% yield, weighing on sentiment.

Pfizer Inc. (NYSE:PFE) is one of the most undervalued blue chip stocks to buy according to hedge funds. Analyst Tim Anderson ...

Disclosure: None. This article is originally published at Insider Monkey.

The market is set to reach USD 1.69 billion by 2035, growing at a 5.2% CAGR from its 2025 valuation of USD 1.01 billion. This ...

Pfizer, Inc. (PFE) stock still looks cheap ahead of its upcoming Aug. 5 Q2 earnings release. Moreover, investors can make extra income by selling out-of-the-money (OTM) put options. This article ...